Projects per year
Fingerprint
Dive into the research topics where Hannah Choe is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Finished
-
A Day 14 Endpoint for Acute GVHD Clinical Trials
Spyrou, N., Akahoshi, Y., Kowalyk, S., Morales, G., Beheshti, R., Aguayo-Hiraldo, P., Al Malki, M. M., Ayuk, F., Bader, P., Baez, J., Capellini, A., Choe, H., DeFilipp, Z., Eder, M., Eng, G., Etra, A., Gleich, S., Grupp, S. A., Hexner, E., Hoepting, M., & 21 others , Apr 2024, In: Transplantation and Cellular Therapy. 30, 4, p. 421-432 12 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
A phase II randomized, placebo-controlled, multicenter trial to evaluate the efficacy of cytomegalovirus PepVax vaccine in preventing cytomegalovirus reactivation and disease after allogeneic hematopoietic stem cell transplant
Nakamura, R., La Rosa, C., Yang, D., Hill, J. A., Rashidi, A., Choe, H., Zhou, Q., Lingaraju, C. R., Kaltcheva, T., Longmate, J., Drake, J., Slape, C., Duarte, L., Al Malki, M. M., Pullarkat, V. A., Aribi, A., Devine, S., Verneris, M. R., Miller, J. S., Forman, S. J., & 2 others , 2024, In: Haematologica.Research output: Contribution to journal › Article › peer-review
Open Access -
A randomized phase 2 trial of oral vitamin A for graft-versus-host disease in children and young adults
Khandelwal, P., Langenberg, L., Luebbering, N., Lake, K. E., Butcher, A., Bota, K., Ramos, K. N., Taggart, C., Choe, H., Vasu, S., Teusink-Cross, A., Koo, J., Wallace, G., Romick-Rosendale, L., Watanabe-Chailland, M., Haslam, D. B., Lane, A. & Davies, S. M., Mar 21 2024, In: Blood. 143, 12, p. 1181-1192 12 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
CRISPR/Cas9 deletion of MIR155HG in human T cells reduces incidence and severity of acute GVHD in a xenogeneic model
Neidemire-Colley, L., Khanal, S., Braunreiter, K. M., Gao, Y., Kumar, R., Snyder, K. J., Weber, M. A., Surana, S., Toirov, O., Karunasiri, M., Duszynski, M. E., Chi, M., Malik, P., Kalyan, S., Chan, W. K., Kararoudi, M. N., Choe, H. K., Garzon, R. & Ranganathan, P., Feb 27 2024, In: Blood Advances. 8, 4, p. 947-958 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002
Meyers, G., Hamadani, M., Martens, M., Ali, H., Chevallier, P., Choe, H., Harris, A. C., Holler, E., van Hooren, E., Klaassen, W., Leifer, E., van Oosterhout, Y., Perez, L., Pusic, I., Stelljes, M., van der Velden, W., Ammatuna, E., Beauvais, D., Cornillon, J., Maziarz, R. T., & 5 others , Dec 2023, In: Bone Marrow Transplantation. 58, 12, p. 1416-1418 3 p.Research output: Contribution to journal › Letter › peer-review
1 Scopus citations